Model N
Revenue Management
- Website
- modeln.com · all feeds from this site
- Feed URL
https://www.modeln.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
How Pharma Companies Are Already Responding to MFN
Insmed delayed Germany. Pfizer struck a manufacturing deal with the White House. Here’s what the pattern tells us. In our first article, we mapped the mechanics of Most-Favored Nation (MFN) pricing and the highest-exposure areas it creates. Now the question shifts from what is…
-
Why Hybrid Revenue Management Is Becoming a Strategic Imperative
Revenue operations in life sciences are facing unprecedented pressure. Regulatory change is constant. Pricing and compliance requirements are expanding. Talent is increasingly specialized—and increasingly scarce. Yet many organizations are still operating with delivery models…
-
Why Global Pharmaceutical Pricing Just Got Complicated
A tender decision in Poland just impacted U.S. rebates. Here’s why that’s about to happen constantly. For the past 25 years, pharmaceutical pricing has operated under a clear geographic hierarchy. The U.S. was expensive, with list prices often three times higher than peer…
-
Adapting Life Sciences Pricing and Tenders for EU HTA and ESG
Life sciences manufacturers are currently navigating a convergence of powerful market forces that are reshaping life sciences pricing strategy across Europe. The evolving regulatory landscape of the EU Health Technology Assessment (HTA) called the Joint Clinical Assessment…
-
HRSA’s 340B Rebate Pilot Release Signals a Shift in Drug Discount Management
HRSA’s release of the revised 340B Rebate Pilot Program on July 31, 2026, is another indication that the administration recognizes effective drug discount management is increasingly dependent on claims-and encounter-level data. While the revised pilot applies only to…